Skip to main content
OUTCOME
2.3
Access to health technologies, innovation, and production
Build resilient health systems for universal access to health and universal health coverage based on primary health care
PB
2026-2027
Access to health technologies, innovation, and production
2.3. Increased equitable access to and rational use of quality, affordable, and effective medicines, vaccines, diagnostics and other health technologies and services, strengthening innovation and production, generating ecosystems, and addressing access barriers across the full life cycle of health technologies
Budget
Approved Budget PB (Previous)
41.5
US$ MILLION
Priority

Low

Proposed Budget PB (Current)
39.3
US$ MILLION
Related Outputs and Indicators
  • 2.3.1.a Number of countries and territories provided with technical cooperation to develop policies, strategies, and/or regulations for timely and equitable access to affordable health technologies
    Baseline
    3
    Target
    12
  • 2.3.1.b Number of countries and territories implementing policies, strategies, and/or regulations for timely and equitable access to affordable health technologies
    Baseline
    9
    Target
    12
  • 2.3.2.a Number of countries and territories provided with technical cooperation to develop and/or implement Institutional Development Plans to strengthen regulatory capacities
    Baseline
    2
    Target
    20
  • 2.3.2.b Number of countries and territories that have established an IDP to improve regulatory capacity for health technologies based on the assessment of their national regulatory capacities by the WHO Global Benchmarking Tool
    Baseline
    3
    Target
    18
  • 2.3.3.a Number of countries and territories provided with technical cooperation to develop and implement policies, strategies, and/or programs for innovation and production of health technologies
    Baseline
    0
    Target
    6
  • 2.3.3.b Number of countries and territories implementing policies, strategies, and/or programs for innovation and production of health technologies
    Baseline
    4
    Target
    7
  • 2.3.4.a Number of countries and territories provided with technical cooperation to increase access to pharmaceutical, blood, transplant, and radiological services
    Baseline
    1
    Target
    3
  • 2.3.4.b Number of countries and territories implementing a plan to increase access to pharmaceutical, blood, transplant, and radiological services
    Baseline
    2
    Target
    6
  • 2.3.5.a Number of countries and territories provided with technical cooperation to develop and enhance institutional frameworks and/or strategies for health technology assessment, incorporation, and/or management
    Baseline
    2
    Target
    12
  • 2.3.5.b Number of countries and territories implementing institutional frameworks and/or strategies for health technology assessment, incorporation, and/or management
    Baseline
    4
    Target
    8
  • 2.3.6 a Number of countries and territories provided with technical cooperation to develop strategies and/or mechanisms for improving rational use of health technologies, such as antimicrobial stewardship

    Baseline
    7
    Target
    7
  • 2.3.6.b Number of countries and territories that implement strategies and/or mechanisms for improving the rational use of health technologies, such as antimicrobial stewardship
    Baseline
    3
    Target
    3
  • 2.3.7.a Number of product items with supplier agreements through the Regional Revolving Funds that are available to Member States
    Baseline
    398 (Baseline 2024)
    Target
    420
  • 2.3.7.b Number of health programs in countries and territories for which health technologies are procured through the Regional Revolving Funds
    Baseline
    105/420 (Baseline 2024)
    Target
    115/420